Protagonist Therapeutics Inc

NASDAQ:PTGX   4:00:00 PM EDT
22.74
-0.04 (-0.18%)
4:55:03 PM EDT: $22.28 -0.46 (-2.02%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.17B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2 Million
Adjusted EPS-$0.73
See more estimates
10-Day MA$22.61
50-Day MA$16.46
200-Day MA$10.81
See more pivots

Protagonist Therapeutics Inc Stock, NASDAQ:PTGX

7707 Gateway Boulevard, Suite 140, Newark, California 94560-1160
Phone: +1.510.474.0170
Number of Employees: 105

Description

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline include PTG-300, PTG-200, and PN-943 The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.